Skip to main content

Table 1 Patient demographics

From: Mitral annular disjunction in surgical mitral valve prolapse: prevalence, characteristics and outcomes

 

Total (n = 111)

MAD (n = 32)

No MAD (n = 79)

p-value

Age (years)

66.3 (59.5–74.5)

64.0 (52.5–71.8)

67.6 (60.3–75.2)

0.042

Sex (female)

33 (29.7%)

14 (43.8%)

19 (24.1%)

0.040

Current smoker

3(2.7%)

2 6.3%)

1 (1.3%)

0.200

Ex-smoker

46 (41.4%)

11 (34.4%)

35 (44.3%)

0.340

Diabetes

7 (6.3%)

1 (3.1%)

6 (7.6%)

0.670

Hyperlipidaemia

48 (43.2%)

8 (25.0%)

40 (50.6%)

0.014

Dialysis

1 (0.9%)

0 (0.0%)

1 (1.3%)

1.000

Hypertension

47 (42.3%)

7 (21.9%)

40 (50.6%)

0.005

Stroke

7 (6.3%)

0 (0.0%)

7 (8.9%)

0.190

PVD

3 (2.7%)

0 (0.0%)

3 (3.8%)

0.560

Previous MI

3 (2.7%)

0 (0.0%)

3 (3.8%)

0.560

History of CCF

39 (35.1%)

10 (31.3%)

29 (36.7%)

0.590

NYHA class

   

0.68

 1

32 (28%)

11 (34.4%)

21 (26.6%)

 

 2

51 (45.9%)

15 (46.9%)

36 (45.6%)

 

 3

21 (18.9%)

4 (12.5%)

17 (21.5%)

 

 4

7 (6.3%)

2 (6.3%)

5 (6.3%)

 

Pre-op AF/Flutter

25 (22.5)

7 (21.9)

18 (22.8)

1.00

Previous CABG

3 (2.7%)

0 (0.0%)

3 (3.8%)

0.56

Previous PCI

6 (5.4%)

1 (3.1%)

5 (6.3%)

0.67

CAD requiring revascularisation

24 (21.6%)

4 (12.5%)

20 (25.3%)

0.14

Concurrent CABG

18 (16.2%)

3 (9.4%)

15 (19%)

0.27

Mitral valve Surgery performed

   

0.11

 Repair

89 (80.2%)

29 (90.6%)

60 (75.9%)

 

 Replacement

22 (19.8%)

3 (9.4%)

19 (24.1%)

 

 ECG—inferior TWI

11 (9.3%)

9 (28.1%)

2 (2.5%)

 < 0.001

 ECG—VEBs

5 (4.5%)

4 (9.4%)

1 (1.1%)

0.007

  1. PVD Peripheral vascular disease, MI Myocardial infarction, CCF Congestive cardiac failure, NYHA New York heart association, AF Atrial fibrillation, CABG Coronary artery bypass grafting, PCI Percutaneous coronary intervention, CAD Coronary artery disease, ECG Electrocardiogram, TWI T wave inversion, VEBs Ventricular ectopic beats